Skip to main content
Envío gratis en todos los pedidos
888-559-3802
VitabaseIngredientes

apoaequorina

Condiciones de Salud16
Tabla de contenidos

Otros Nombres

(2S)-2,5-Diaminopentanoic acid(2S)-2,5-Diaminovaleric acid(S)-2,5-Diaminopentanoic acid(S)-2,5-Diaminovaleric acid(S)-alpha,delta-Diaminovaleric acid(S)-Ornithine(S)-α,δ-Diaminovaleric acid2,5-Diaminopentanoic acid2,5-Diaminovaleric acid5-Amino-L-norvalineChlorhydrate d'OrnithineH-Orn-OHL-2,5-Diaminovaleric acidL-Norvaline, 5-amino-L-Ornithinlaevo-ornithinelevo-ornithineOrnOrnithineOrnithine (VAN)Ornithine [INN]Ornithine, L-OrnithinumOrnitinaPentanoic acid, 2,5-diamino-, (S)-α,δ-Diaminovaleric acidорнитинأورنيثين鳥氨酸鸟氨酸

Sinopsis

Historia

La apoequorina es una proteína única originalmente aislada de la medusa Aequorea victoria. Descubierta en la década de 1960, esta proteína bioluminiscente atrajo la atención por su notable capacidad para unirse a iones de calcio y emitir luz, una propiedad que revolucionó la investigación celular. Si bien la apoequorina en sí misma no tiene raíces en la medicina herbal tradicional, su incorporación a los productos medicinales y nutricionales representa un avance emocionante en el campo de la salud cognitiva.

Históricamente, la apoequorina se ha utilizado principalmente en la investigación científica más que como remedio popular. Su aplicación en suplementos de salud modernos surgió a principios del siglo XXI, con productos destinados a apoyar la memoria y la función cognitiva, particularmente en poblaciones de edad avanzada. Las afirmaciones contemporáneas destacan el potencial de la apoequorina para promover la claridad mental, la concentración y la salud cerebral en general, enfatizando a menudo su papel en el mantenimiento de la homeostasis del calcio en las neuronas, un aspecto esencial del envejecimiento cerebral saludable.

En el ámbito de los productos nutricionales, la apoequorina se combina a veces con extractos herbales como ginkgo biloba, bacopa monnieri o fosfatidilserina. Estas combinaciones buscan sinergizar los beneficios de las propiedades neuroprotectoras únicas de la apoequorina con los remedios herbales tradicionales conocidos por su apoyo cognitivo. La integración de la apoequorina en estas mezclas ofrece a los consumidores un enfoque novedoso para la salud cerebral, fusionando la innovación científica con la sabiduría botánica consagrada por el tiempo.

En general, la apoequorina representa un ingrediente prometedor en el panorama de los suplementos nutricionales, reuniendo lo mejor de la ciencia moderna de proteínas y el poder complementario de la medicina herbal para apoyar la vitalidad cognitiva y el bienestar.

Validación tradicional y científica

La apoequorina es una proteína derivada originalmente de la medusa Aequorea victoria. Es más conocida por su papel en la investigación de la bioluminiscencia, especialmente en el descubrimiento que condujo al Premio Nobel de Química en 2008. En los últimos años, la apoequorina se ha incorporado a los suplementos nutricionales, principalmente en productos comercializados para el apoyo cognitivo y la mejora de la memoria.

El principal interés científico en la apoequorina dentro de los productos nutricionales se basa en sus propiedades de unión al calcio. Los iones de calcio desempeñan un papel crucial en la señalización neuronal y la función cerebral, y se ha planteado la hipótesis de que la apoequorina podría ayudar a regular los niveles de calcio intracelular, apoyando potencialmente la salud cognitiva. Algunos estudios de laboratorio preliminares sugieren que la apoequorina puede influir en la homeostasis del calcio en las células, pero el mecanismo exacto y su relevancia en los seres humanos no se comprenden completamente.

La investigación clínica sobre la eficacia de la apoequorina en seres humanos es limitada. Un estudio notable publicado en 2016 investigó los efectos de un suplemento que contiene apoequorina sobre la memoria en adultos mayores. Los resultados indicaron una mejora modesta en ciertos aspectos de la función cognitiva, como el aprendizaje verbal y la memoria, en comparación con un placebo. Sin embargo, las mejoras fueron limitadas y se necesitan estudios independientes adicionales a gran escala para confirmar estos hallazgos y establecer la seguridad a largo plazo.

Si bien la validación científica para el uso de la apoequorina en productos nutricionales aún está surgiendo, sus propiedades biológicas únicas y los hallazgos positivos iniciales destacan su potencial como ingrediente novedoso. La investigación continua puede esclarecer aún más sus beneficios para la salud cognitiva y el bienestar general.

Condiciones de Salud

Condiciones de salud que apoaequorina puede ayudar a apoyar.

  • Acidez EstomacalCientífico

    In the Miyake et al. 2014 RCT, L-ornithine (400 mg/day, 8 weeks) significantly reduced POMS tension-anxiety subscores in healthy workers with mild stress. Animal studies demonstrate that orally administered L-ornithine attenuates corticotropin-releasing factor (CRF)-induced distress vocalizations and anxiety-like behavior via GABA-A receptors in neonatal chicks. The human POMS evidence is modest in scale but the finding is replicated across studies measuring mood states.

  • Human RCTs show L-ornithine can improve measures of anaerobic performance and attenuate fatigue during exercise protocols, primarily through enhanced ammonia clearance. An RCT in 10 trained adults (Eur J Appl Physiol 2011) found significantly greater peak cycling RPM with L-ornithine. Another RCT (Nutrition Research 2008) documented reduced subjective fatigue and preserved physical output. However, not all studies show direct performance improvement; effects on maximal short-term power remain mixed.

  • AmenorreaCientífico

    L-ornithine has been shown in human RCTs to reduce POMS tension, anger, and fatigue subscores, consistent with a calming effect. The 2013 crossover RCT by Kokubo et al. showed meaningfully better mood and sleep quality scores with 400 mg L-ornithine versus placebo in a stress context. The mechanistic basis includes GABA-A receptor modulation and serotonin pathway activity observed in preclinical studies.

  • Multiple human RCTs show L-ornithine reduces subjective fatigue in both physical and psychosocial stress contexts. Sugino et al. found significant anti-fatigue effects on a VAS scale and physical performance during prolonged cycling. The 2014 Miyake et al. 8-week RCT reported sustained improvements in fatigue-related POMS subscales in workers with low-grade fatigue taking 400 mg/day. The proposed mechanism involves urea cycle-mediated ammonia clearance and upregulation of lipid metabolism via growth hormone.

  • L-ornithine has been hypothesized and experimentally shown to influence circadian rhythms. Research shows it elevates striatal serotonin metabolite 5-HIAA, which drives nocturnal melatonin production and supports sleep-wake cycling. A randomized crossover trial (Chronobiol Int 2018) investigated L-ornithine's direct effect on the human circadian clock. Mouse studies in Scientific Reports (2016) confirmed that L-ornithine affects peripheral clock gene expression.

  • L-ornithine has been shown to attenuate physical fatigue and improve energy-related outcomes by activating the urea cycle to clear ammonia and by promoting lipid oxidation via growth hormone stimulation. A double-blind crossover study (Sugino et al., Nutrition Research 2008) showed L-ornithine reduced subjective fatigue on the visual analog scale and improved physical performance in female subjects. The 2024 TSST RCT also confirmed that L-ornithine improved fatigue-inertia scores following social stress.

  • ForúnculosCientífico

    L-ornithine is an amino acid that has been shown to augment post-exercise GH levels. A 2010 clinical study found that L-ornithine (100 mg/kg) administered 30 minutes after exercise produced a significantly greater GH peak compared to controls. L-ornithine is also a component of OKG, which has documented GH-stimulating activity in clinical nutritional studies.

  • L-ornithine is a central intermediate of the hepatic urea cycle, converting toxic ammonia to urea. As the L-ornithine L-aspartate (LOLA) formulation, it is clinically used to treat hepatic encephalopathy (HE) in cirrhosis, with meta-analyses of multiple RCTs confirming significant reductions in blood ammonia and improvements in mental state. Evidence also includes direct hepatoprotective effects such as reductions in liver enzymes and improvements in MELD scores.

  • L-ornithine supports muscle recovery primarily by enhancing ammonia clearance via the urea cycle, which reduces post-exercise ammonia accumulation—a key contributor to muscle fatigue. A European Journal of Applied Physiology RCT found significantly greater peak cycling RPM with L-ornithine versus placebo in an intermittent anaerobic protocol. L-ornithine also promotes GH secretion from the pituitary, supporting muscle protein synthesis.

  • L-ornithine is a urea cycle intermediate that supports NO production by feeding the ornithine-citrulline-arginine recycling pathway. Ornithine is converted to citrulline, which is then converted to arginine for eNOS-mediated NO synthesis, making it an indirect but metabolically established contributor to the arginine pool available for NO generation.

  • L-ornithine has been shown in human crossover RCTs to improve ammonia buffering during sustained endurance exercise, reducing the build-up of a central fatigue agent. The Sugino et al. 2008 study found L-ornithine attenuated fatigue and performance decline during 3.5-hour cycling. In an EJCN study with 14 trained adults, L-ornithine increased ammonia buffering capacity during and after exhaustive incremental ergometry.

  • Costra lácteaCientífico

    A randomized, double-blind, placebo-controlled 8-week trial (Ito et al., Marine Drugs 2018) found that a composite supplement of collagen peptide and L-ornithine significantly improved skin elasticity and transepidermal water loss (TEWL) compared to placebo in 22 healthy Japanese participants. Only the ornithine-containing supplement group showed significantly increased plasma IGF-1 after 8 weeks. L-ornithine's GH-stimulating effect and its role as a proline/collagen precursor are the proposed mechanisms.

  • L-ornithine is a biochemical precursor to proline (the structural backbone of collagen) and to polyamines required for fibroblast proliferation. The Ito et al. Marine Drugs 2018 RCT found collagen peptide plus ornithine significantly improved skin elasticity and TEWL versus placebo, with elevated IGF-1 only in the treated group. Mouse studies confirm oral L-ornithine increases collagen-constituting amino acids and polyamines in skin tissue.

  • A randomized, double-blind, placebo-controlled trial in 52 healthy Japanese workers found that 400 mg/day of L-ornithine for 8 weeks significantly improved perceived sleep quality on the Athens Insomnia Scale and the OSA-MA sleep inventory. Serum cortisol and the cortisol/DHEA-S ratio were also significantly reduced in the L-ornithine group. A separate crossover RCT confirmed improved sleep scores in subjects taking 400 mg L-ornithine after alcohol consumption. The proposed mechanism involves L-ornithine-driven increases in striatal serotonin metabolite (5-HIAA), which promotes nocturnal melatonin synthesis.

  • Multiple human RCTs demonstrate that L-ornithine reduces biochemical and subjective stress markers. An 8-week RCT in 52 workers showed L-ornithine significantly lowered serum cortisol, the cortisol/DHEA-S ratio, and anger on the POMS scale. A 2024 parallel-group RCT using the Trier Social Stress Test (TSST) in 65 participants found L-ornithine (1,600 mg/day for 7 days) significantly improved fatigue-inertia and anger-hostility POMS subscales the morning after social stress. The mechanism likely involves modulation of the hypothalamic-pituitary-adrenal (HPA) axis.

  • DifteriaCientífico

    Ornithine is a metabolic precursor to proline (a collagen building block) and polyamines (required for cell proliferation), making it mechanistically central to wound repair. Animal studies (Shi et al., J Surg Res 2002) showed dietary ornithine supplementation significantly enhanced wound breaking strength and collagen deposition. The NCATS database notes ornithine may have wound-healing activity via arginine metabolism under stress conditions, though robust human wound-healing trials are limited.

Sistemas Corporales

Sistemas corporales que apoaequorina puede ayudar a apoyar.

  • No hay sistemas corporales disponibles.
Únete a nuestro boletín

Mantente informado. Mantente saludable.

Recibe consejos de suplementos de expertos, descuentos exclusivos y recomendaciones de productos en tu bandeja de entrada